Molecular changes in myocardium in the course of anemia or iron deficiency

Heart Failure Clinics
Ewa A Jankowska, Piotr Ponikowski

Abstract

Chronic untreated anemia or iron deficiency (ID) can result in an increased cardiac output, chronic sympathetic activation, left ventricular hypertrophy, and left ventricular dilation, leading to symptomatic chronic heart failure (CHF). Only in the past decade has there been an increase in interest in anemia and ID occurring in the course of CHF. The pharmacologic support in erythropoietin signaling or the correction in iron metabolism may activate molecular pathways that can protect the heart and prevent myocardial remodeling, and hence become a novel therapeutic approach in patients with CHF. Most of the data come from experimental models. Further studies, in particular performed in clinical settings, are warranted.

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P KubesD N Granger
Sep 1, 1990·The Journal of Clinical Investigation·A D D'Andrea, L I Zon
Nov 1, 1989·Circulation Research·G OlivettiP Anversa
Aug 25, 1988·The New England Journal of Medicine·P M Vanhoutte
Apr 1, 1969·Circulation·M Duke, W H Abelmann
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·A AnagnostouC T Noguchi
May 18, 1994·Biochemical Pharmacology·Z TanneM B Youdim
Apr 1, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J PortolésA Barrientos
Aug 26, 1998·Proceedings of the Society for Experimental Biology and Medicine·D M Medeiros, J L Beard
Feb 13, 1999·Kidney International·R G CarliniE Bellorin-Font
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L BrinesA Cerami
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·F T RuschitzkaM Gassmann
Dec 18, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Per Ole IversenGeir Christensen
Apr 26, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Zhao Zhong ChongKenneth Maiese
Jun 20, 2002·The Journal of Biological Chemistry·Katsutoshi Ozaki, Warren J Leonard
Nov 29, 2002·Stem Cells·Terence R LappinPatrick G Johnston
Mar 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Laura CalvilloMichael Brines
Jun 26, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marc HeidbrederPeter Dominiak
Aug 21, 2003·Biochemical and Biophysical Research Communications·Anthony F TramontanoNabil El-Sherif
Sep 23, 2003·Cardiovascular Research·Kyle J SmithDavid C Sane
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Chanil MoonMark I Talan
Oct 3, 2003·The Journal of Clinical Investigation·Cyrus J ParsaWalter J Koch
Oct 4, 2003·Blood·Ferdinand H BahlmannDanilo Fliser
Oct 9, 2003·Kidney International·Ferdinand H BahlmannDanilo Fliser
Dec 13, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ferdinand H BahlmannDanilo Fliser
Feb 27, 2004·European Heart Journal·Peter van der MeerDirk J van Veldhuisen
Jun 15, 2004·Medical Hypotheses·C Scoppetta, F Grassi
Jul 6, 2004·Journal of the American College of Cardiology·Peter van der MeerDirk J van Veldhuisen
Aug 24, 2004·Annals of Hematology·Wolfgang Jelkmann, Klaus Wagner
Oct 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael BrinesAnthony Cerami
Nov 24, 2004·European Journal of Heart Failure·Peter van der MeerWiek H van Gilst
Dec 3, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Danilo FliserHermann Haller
Dec 14, 2004·The Oncologist·Francis Farrell, Adrian Lee

❮ Previous
Next ❯

Citations

Sep 4, 2012·Current Heart Failure Reports·Shanti Gunawardena, Mark E Dunlap
Aug 1, 2013·Herz·S RedaU C Hoppe
Sep 6, 2012·Heart Failure Reviews·Natasha P Arora, Jalal K Ghali
Dec 17, 2015·Heart, Lung & Circulation·Christopher C Y WongAndrew P Sindone
Mar 25, 2014·Heart Failure Clinics·Natasha P Arora, Jalal K Ghali
Jul 23, 2011·Journal of the American College of Cardiology·John McMurray, Piotr Ponikowski
Feb 26, 2015·Journal of Hypertension·Yoshiro NaitoTohru Masuyama
Apr 29, 2014·International Journal of Cardiology·Cristina EnjuanesJosep Comín-Colet
Jul 18, 2018·Journal of the Science of Food and Agriculture·Mª José Muñoz AlférezJavier Díaz-Castro
Oct 21, 2017·Current Medical Research and Opinion·Khaled M Musallam, Ali T Taher
Dec 23, 2020·Journal of Electrocardiology·Emre Yilmaz, Ercan Aydin
May 14, 2021·Circulation Research·Joyce N Njoroge, John R Teerlink

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

American Journal of Physiology. Heart and Circulatory Physiology
Yoshiro NaitoTohru Masuyama
Current Treatment Options in Cardiovascular Medicine
Eileen O'Meara, Simon de Denus
International Journal of Cardiology
Przemysław LeszekMarcin Kruszewski
© 2021 Meta ULC. All rights reserved